Pubblicazioni Scientifiche
Dermatologia13 gen 2021
Pruritus Intensity Scales across Europe: A Prospective Validation Study
Chronic pruritus (CP) is a subjective symptom and it is necessary to assess its intensity with validated patient-reported outcome tools in order to allow determination of the treatment course
13 gen 2021
Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors
Checkpoint inhibitor (CPI) therapy has vastly improved long-term outcomes in metastatic malignant melanoma (MMM)
14 dic 2020
Androgenetic alopecia in women and men
Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines
14 dic 2020
Immune checkpoint-mediated psoriasis
A multicentric European study of 115 patients from European Network for Cutaneous ADverse Event to Oncologic drugs (ENCADO) group
14 dic 2020
Dermatoscopy of combined blue nevi: A multicenter study of the International Dermoscopy Society
Combined blue nevi may mimic melanoma and are relatively often biopsied for diagnostic reasons.
10 dic 2020
COVID-19 and Skin Manifestations: An Overview of Case Reports/Case Series and Meta-Analysis of Prevalence Studies
Since the onset of the 2019-nCoV disease (COVID-19), many skin manifestations have been reported in COVID-19 patients
10 dic 2020
Skin barrier immunity and ageing
The skin is the outermost layer of the body with an extensive surface area of approximately 1·8 m2, and is the first line of defence against a multitude of external pathogens and environmental insults.
02 dic 2020
The 2020 International Alliance for the Control of Scabies
Consensus Criteria for the Diagnosis of Scabies
02 dic 2020
Prurigo nodularis
Pathogenesis and management
02 dic 2020
Clinical and Dermoscopic Features of Vulvar Melanosis Over the Last 20 Years
In this cohort study of 129 patients with vulvar melanosis and 5 to 20 years of follow-up, 67% of vulvar melanotic lesions appeared in premenopausal patients, and 65% of all patients had received some type of hormone therapy;
24 nov 2020
Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic
Risk Analysis from the PSO-BIO-COVID Observational Study
24 nov 2020
Autoimmunity in Segmental Vitiligo
The autoimmune basis of segmental vitiligo (SV) has only recently been recognized.
24 nov 2020
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and Abrocitinib
Atopic dermatitis is a common, chronic, immune-mediated disease associated with several comorbidities.
17 nov 2020
DIAGNOSTIC ACCURACY OF DERMOSCOPY OF ACTINIC KERATOSIS: A SYSTEMATIC REVIEW
Dermoscopy is a tool that aids clinicians in the diagnosis of actinic keratosis;
17 nov 2020
Cutaneous Melanoma Arising in Congenital Melanocytic Nevus
A Retrospective Observational Study
17 nov 2020
5‐Alpha‐Reductase Inhibitors are Associated with Reduced Frequency of COVID‐19 Symptoms in Males with Androgenetic Alopecia
We have previously reported that men with androgenetic alopecia (AGA) are more likely to present with severe COVID‐19 symptoms, potentially implicating androgen sensitivity as a risk factor for COVID‐19.
11 nov 2020
Real-world effectiveness and tolerability of dupilumab in adult atopic dermatitis
Real‐world effectiveness and tolerability of dupilumab in adult atopic dermatitis: A single centre, prospective one‐year observational cohort study of the first 100 patients treated
11 nov 2020
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale
Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma
03 nov 2020
Special aspects of biologics treatment in psoriasis: management in pregnancy, lactation, surgery, renal impairment, hepatitis and tuberculosis
Biologics are modern immunomodulatory drugs, whose use in the treatment of psoriasis has led to remarkable results in psoriatic patients. The administration of these agents in special population groups, such as patients with chronic infections and renal impairment, as well as perioperative, pregnant or lactating patients, has not been thoroughly addressed, mostly because these patients are excluded from clinical studies.
03 nov 2020
Analysis of cutaneous Merkel cell carcinoma outcomes after different surgical interventions
Current guidelines recommend local excision margin (EM) with 1 to 2 cm on primary Merkel cell carcinoma (MCC) sites.